Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in Clearside Biomedical, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- 0 vs. Q4 2024
- Shares held
- 8.81M
- −626.9K (−6.6%) vs. Q4 2024
- Total value
- $8.09M
- −$878.7K (−9.8%) vs. Q4 2024
- New holders
- 4
- 5 more added
- Sold out
- 4
- 15 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLSD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $3.26K |
| Q1 2026 | 1 | $7.87K |
| Q4 2025 | 1 | $19.1K |
| Q3 2025 | 26 | $2.18M |
| Q2 2025 | 45 | $7.51M |
| Q1 2025 | 44 | $8.09M |
| Q4 2024 | 44 | $8.97M |
| Q3 2024 | 49 | $12.7M |
| Q2 2024 | 49 | $17.9M |
| Q1 2024 | 52 | $23.8M |
| Q4 2023 | 48 | $9.06M |
| Q3 2023 | 46 | $6.82M |
| Q2 2023 | 54 | $9.62M |
| Q1 2023 | 51 | $9.09M |
| Q4 2022 | 53 | $10.2M |
| Q3 2022 | 54 | $13.6M |
| Q2 2022 | 53 | $20.1M |
| Q1 2022 | 60 | $37.5M |
| Q4 2021 | 67 | $57.8M |
| Q3 2021 | 66 | $121.5M |
| Q2 2021 | 53 | $95.8M |
| Q1 2021 | 52 | $43.8M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Clearside Biomedical, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 2,806,607 | $2.58M | 0.00% | 00.0% | Unchanged |
| Carmignac Gestion | 1,508,342 | $1.38M | 0.02% | −425,189−22.0% | Reduced |
| BlackRock, Inc. | 800,920 | $735.2K | 0.00% | −76,727−8.7% | Reduced |
| Geode Capital Management, LLC | 792,247 | $727.4K | 0.00% | +28,189+3.7% | Added |
| Renaissance Technologies LLC | 554,512 | $509.0K | 0.00% | −167,277−23.2% | Reduced |
| First Manhattan Co | 342,725 | $314.6K | 0.00% | −62,943−15.5% | Reduced |
| State Street Corp | 265,263 | $243.5K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 255,000 | $234.1K | 0.01% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 201,589 | $185.0K | 0.02% | +201,589 | New |
| Northern Trust Corp | 165,499 | $151.9K | 0.00% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 131,913 | $121.1K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 130,896 | $120.2K | 0.00% | −1,102−0.8% | Reduced |
| The PNC Financial Services Group, Inc. | 107,919 | $99.1K | 0.00% | −325−0.3% | Reduced |
| Brown Wealth Management, LLC | 100,000 | $91.8K | 0.03% | 00.0% | Unchanged |
| Northeast Financial Consultants Inc | 93,000 | $85.4K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 87,000 | $79.9K | 0.00% | −14,208−14.0% | Reduced |
| UBS Group AG | 62,069 | $57.0K | 0.00% | −83,049−57.2% | Reduced |
| Investor's Fiduciary Advisor Network, LLC | 33,800 | $31.0K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 33,169 | $30.4K | 0.00% | −25,869−43.8% | Reduced |
| Newman Dignan & Sheerar, Inc. | 30,123 | $27.6K | 0.01% | 00.0% | Unchanged |
| Synovus Financial Corp | 30,000 | $27.5K | 0.00% | 00.0% | Unchanged |
| PKS Advisory Services, LLC | 24,500 | $22.5K | 0.01% | 00.0% | Unchanged |
| Prudential Financial Inc | 24,400 | $22.4K | 0.00% | +5,000+25.8% | Added |
| Stifel Financial Corp | 23,944 | $22.0K | 0.00% | 00.0% | Unchanged |
| Westmount Partners, LLC | 23,400 | $21.5K | 0.01% | +1,900+8.8% | Added |
| Commonwealth Equity Services, LLC | 22,500 | $21.0K | 0.00% | +12,500+125.0% | Added |
| Two Sigma Securities, LLC | 20,911 | $19.2K | 0.00% | −285−1.3% | Reduced |
| Mariner, LLC | 18,950 | $17.4K | 0.00% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 18,411 | $16.9K | 0.00% | +18,411 | New |
| Warren Averett Asset Management, LLC | 18,380 | $16.9K | 0.00% | −3,585−16.3% | Reduced |
| Advisor Resource Council | 15,000 | $13.8K | 0.00% | +15,000 | New |
| Oppenheimer & Co Inc | 14,341 | $13.2K | 0.00% | 00.0% | Unchanged |
| Stratos Wealth Advisors, LLC | 14,000 | $12.9K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 10,500 | $10.0K | 0.00% | 00.0% | Unchanged |
| Rockwood Wealth Management, LLC | 10,000 | $9.18K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 9,980 | $9.16K | 0.00% | −378−3.6% | Reduced |
| Tower Research Capital LLC (TRC) | 4,918 | $4.51K | 0.00% | −1,093−18.2% | Reduced |
| Bank of America Corp | 1,905 | $1.75K | 0.00% | −4,526−70.4% | Reduced |
| Advisor Group Holdings, Inc. | 1,000 | $920 | 0.00% | −200−16.7% | Reduced |
| Larson Financial Group LLC | 1,000 | $918 | 0.00% | +1,000 | New |
| CIBC Private Wealth Group, LLC | 1,100 | $901 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 485 | $445 | 0.00% | +105+27.6% | Added |
| Creative Financial Designs Inc | 100 | $92 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −20,216−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,505−100.0% | Sold out |
| Malaga Cove Capital, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −145−100.0% | Sold out |